Advertisement

Search Results for "The Annual Sales Of Abilify In Us"

04:52 EDT 20th May 2013 | BioPortfolio

Original Source: Abilify

Abilify (Aripiprazole) is an atypical antipsychotic produced by Bristol-Myers Squibb Company, with annual sales of $3m, ranking it 6th in the world for annual sales.  Abilify is prescribed in addition to other anti-depressants for the treatment of...

Matching Channels

Abilify

Abilify (Aripiprazole) is an atypical antipsychotic produced by Bristol-Myers Squibb Company, with annual sales of $3m, ranking it 6th in the world for annual sales.  Abilify is prescribed in...

Pfizer

Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have...

Johnson and Johnson

Johnson & Johnson is a leading pharmaceutical and healthcare company, with annual sales in 2009 of $22,520 million, ranking it the 8th largest pharmaceutical company in the world (based on sales...

Seroquel

Seroquel, an atypical antipsychotic medication has annual sales of $3.1m (in 2009), and based on annual sales, ranks 5th in the world. It is produced by AstraZeneca Pharmaceuticals as a quetiapine f...

Boehringer Ingelheim

Boehringer Ingelheim is a global pharmaceutical company with annual sales of over $16 billion, making it the 10th largest pharmaceutical company in the world based on sales.  With bases in 47 c...

Matching News

Drugs.com Releases Q4 Sales for Top 100 U.S. Drugs: Abilify Overtakes Nexium as the Top Drug by Sales

NEW YORK, Feb. 7, 2013 /PRNewswire/ -- Drugs.com, the leading online clinical drug resource, today released fourth quarter 2012 U.S. prescription sales data for the top 100 drugs. At the close of 201...

Japanese Abilify growth helps Otsuka ride currency-hit quarter

Currency effects, European cost-saving measures and indirect generic competition weighed on the global sales of Otsuka Holdings' top product, the atypical antipsychotic Abilify (aripiprazole), in the...

FDA Approves Once-Monthly ABILIFY MAINTENA™

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced the FDA has approved ABILIFY MAINTENA™ (aripiprazole) for extended- release injectable suspension, an intramuscular (IM) depot formulati...

Bristol-Myers cutting 479 sales and marketing jobs

Bristol-Myers Squibb Co. said Tuesday that it is eliminating 479 jobs as its partner Otsuka Pharmaceutical Co. takes over U.S. marketing of the schizophrenia drug Abilify.Bristol-Myers said it is eli...

What Is Abilify (Aripiprazole)

Abilify (aripiprazole), a partial dopamine agonist, is an antipsychotic drug with additional antidepressant qualities. It has been approved for the treatment of schizophrenia, bipolar disorder and dep...

EU accepts filing for monthly Abilify for schizophrenia maintenance

The European Medicines Agency has formally accepted a marketing authorization application for a once-monthly intramuscular depot formulation of Otsuka Pharmaceutical's atypical antipsychotic Abilify...

FDA approves once-monthly Abilify for schizophrenia

(Reuters) - Regulators on Thursday approved a once-monthly injectable form of Abilify, the blockbuster treatment for schizophrenia, which will be sold by Japanese drugmaker Otsuka and Danish drug grou...

Abilify first antipsychotic to be filed for depression in Japan

Otsuka Pharmaceutical has applied for the approval in Japan of the atypical antipsychotic Abilify (aripiprazole) as an adjunctive therapy for major depressive disorder. The submission is specifically...

Matching PubMed Articles

Exercise in Thoroughbred yearlings during sales preparation: A cohort study.

Reasons for performing study: There is increasing evidence suggesting that early exercise in Thoroughbred racehorses may be beneficial to the development of the musculoskeletal system. At present, inf...

The relationship between sales of SSRI, TCA and suicide rates in the Nordic countries.

ABSTRACT: BACKGROUND: In the period 1990-2006, strong and almost equivalent increases in sales figures of selective serotonin re-uptake inhibitors (SSRIs) were observed in all Nordic countries. The sa...

Prediction of gastrointestinal disease with over-the-counter diarrheal remedy sales records in the San Francisco Bay Area.

ABSTRACT: BACKGROUND: Water utilities continue to be interested in implementing syndromic surveillance for the enhanced detection of waterborne disease outbreaks. The authors evaluated the ability of...

Weekly lottery sales volume and suicide numbers: a time series analysis on national data from Taiwan.

OBJECTIVE: To investigate the association between weekly lottery sales and number of suicide deaths in Taiwan. METHODS: All suicides aged 15+ years during 2004-2006 in Taiwan were included. Poisson au...

The Premises is the Premise: Understanding Off- and On-premises Alcohol Sales Outlets to Improve Environmental Alcohol Prevention Strategies.

Environmental strategies to prevent the misuse of alcohol among youth-e.g., use of public policies to restrict minors' access to alcohol-have been shown to reduce underage drinking. However, implement...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement